The publication of this interactive video was organised and funded by Eisai. This webinar reflects the opinions of the speaker and does not necessarily those of its funder, Eisai or EMJ, and is intended for healthcare professionals.
Explore this interactive video featuring neurologist Vicente Villanueva, as he discusses insights from the PERMIT real-world study – a post-hoc analysis of the effectiveness and tolerability of perampanel for epilepsy.
Speakers
Vicente Villanueva1
1. Neurologist and Head of the Refractory Epilepsy Unit and Epilepsy Surgery Programme, Multidisciplinary Epilepsy Unit, Hospital La Fe; Professor of Neurology, University of Valencia, Spain.
Prescribing information for Europe can be accessed here.
Prescribing information for the USA can be accessed here.
Prescribing information for Northern Ireland and Republic of Ireland can be accessed here.
Prescribing information and adverse event reporting for the UK can be accessed here.
EMEA-FYC-24-00073 | October 2025
